drugset / Trial / NCT02670018
BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 2000mg in Comparison to Each Component Administered Alone
RandomizedCrossoverOpen-labelTreatment
Summary
A Randomized, Open-label, Single-dose, Two-way Crossover Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of the Combination of Gemigliptin/Metformin HCl Sustained Release 50/2000 mg(25/1000 mg x 2 tablets) in Comparison to Each Component Gemigliptin 50 mg and Metformin HCl Extended Release 2000 mg (1000 mg x 2 tablets) Administered in Healthy Male Volunteers.
Timeline
- Start
- 2015-08
- Primary completion
- 2015-12
- Completion
- 2016-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Gemigliptin | Small molecule | 25 mg | — |
| Comparator | Gemigliptin | Small molecule | 50 mg | — |
| Comparator | Metformin | Small molecule | 2000 mg | — |
Indications
No indication recorded.